Literature DB >> 31914222

Two-stage Bayesian GWAS of 9576 individuals identifies SNP regions that are targeted by miRNAs inversely expressed in Alzheimer's and cancer.

Gita A Pathak1, Zhengyang Zhou2, Talisa K Silzer1, Robert C Barber3, Nicole R Phillips1.   

Abstract

INTRODUCTION: We compared genetic variants between Alzheimer's disease (AD) and two age-related cancers-breast and prostate -to identify single-nucleotide polymorphisms (SNPs) that are associated with inverse comorbidity of AD and cancer.
METHODS: Bayesian multinomial regression was used to compare sex-stratified cases (AD and cancer) against controls in a two-stage study. A ±500 KB region around each replicated hit was imputed and analyzed after merging individuals from the two stages. The microRNAs (miRNAs) that target the genes involving these SNPs were analyzed for miRNA family enrichment.
RESULTS: We identified 137 variants with inverse odds ratios for AD and cancer located on chromosomes 19, 4, and 5. The mapped miRNAs within the network were enriched for miR-17 and miR-515 families. DISCUSSION: The identified SNPs were rs4298154 (intergenic), within TOMM40/APOE/APOC1, MARK4, CLPTM1, and near the VDAC1/FSTL4 locus. The miRNAs identified in our network have been previously reported to have inverse expression in AD and cancer.
© 2020 the Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's; CLPTM1; FSTL4; GWAS; MARK4; VDAC1; aging; cancer; genetic risk; inverse association; two-stage Bayesian

Year:  2020        PMID: 31914222     DOI: 10.1002/alz.12003

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  8 in total

Review 1.  Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA.

Authors:  Michele Salemi; Maria Paola Mogavero; Giuseppe Lanza; Laura M Mongioì; Aldo E Calogero; Raffaele Ferri
Journal:  Cells       Date:  2022-06-15       Impact factor: 7.666

2.  Associations of risk genes with onset age and plasma biomarkers of Alzheimer's disease: a large case-control study in mainland China.

Authors:  Bin Jiao; Xuewen Xiao; Zhenhua Yuan; Lina Guo; Xinxin Liao; Yafang Zhou; Lu Zhou; Xin Wang; Xixi Liu; Hui Liu; Yaling Jiang; Zhuojie Lin; Yuan Zhu; Qijie Yang; Weiwei Zhang; Jinchen Li; Lu Shen
Journal:  Neuropsychopharmacology       Date:  2022-01-09       Impact factor: 8.294

3.  Microtubule affinity-regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration.

Authors:  Toshiya Oba; Taro Saito; Akiko Asada; Sawako Shimizu; Koichi M Iijima; Kanae Ando
Journal:  J Biol Chem       Date:  2020-10-05       Impact factor: 5.157

4.  MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease Therapy.

Authors:  Anas Shamsi; Saleha Anwar; Taj Mohammad; Mohamed F Alajmi; Afzal Hussain; Md Tabish Rehman; Gulam Mustafa Hasan; Asimul Islam; Md Imtaiyaz Hassan
Journal:  Biomolecules       Date:  2020-05-20

5.  Salvianic Acid A Sodium Promotes the Recovery of Motor Function After Spinal Cord Injury in Rats by Reducing Microglia Inflammation through Regulating MIP2/Vdac1/Ndufa12 Signaling Axis.

Authors:  Liping Li; Yuanyuan Liu; Xia Zhao; Chao Qi; Yi Zhang; Yingze Zhang; Tengbo Yu
Journal:  Orthop Surg       Date:  2020-10-20       Impact factor: 2.071

6.  Association Between Alzheimer Disease and Cancer With Evaluation of Study Biases: A Systematic Review and Meta-analysis.

Authors:  Monica Ospina-Romero; M Maria Glymour; Eleanor Hayes-Larson; Elizabeth Rose Mayeda; Rebecca E Graff; Willa D Brenowitz; Sarah F Ackley; John S Witte; Lindsay C Kobayashi
Journal:  JAMA Netw Open       Date:  2020-11-02

7.  miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology.

Authors:  Le Chang; Guangyan Zhou; Othman Soufan; Jianguo Xia
Journal:  Nucleic Acids Res       Date:  2020-07-02       Impact factor: 16.971

8.  Bioinformatic analysis of the expression and prognosis of ZNF589 in human breast cancer.

Authors:  Jun Fan; Zhe Zhang; Dongjiao Chen; Hongqiang Chen; Wenbo Yuan; Lu Zhou; Jing Xu; Wenbin Liu; Yan Xu
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.